Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
AI-driven capital spending is set to surge, pushing capex crosses trillion next. Here are two industrial stocks—Verti...
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
SpaceX has dazzled investors, but big bets come with big risks. This article explains three reasons reasons spacex st...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
A snack brand’s take-private deal sent its stock surging and offered a clear lesson for investors. This guide breaks ...
President Trump has nominated Kevin Warsh to chair the Federal Reserve, a move that could reshape U.S. monetary polic...
Midsize U.S. firms reduced payments to Chinese suppliers in 2025 as tariff policy remained volatile, signaling a broa...
Apple is reportedly adopting a Netflix style strategy, focusing on originals, bundling, and scalable growth. This art...
LegalZoom stock slipped today as markets digested the latest quarter. This article breaks down the drivers behind the...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...